Live Cetuximab updates

Live Cetuximab news coverage of developments with the latest updates. Stay on top of latest Cetuximab news stories and find out what just happened, what is going on with Cetuximab. The latest real-time news updates and headlines on Cetuximab
EGFR Resistance in Breast, Head & Neck Cancers
Existing Drug Class May Aid Resistant Skin Cancer
Dual Immunotherapy Boosts Survival in Advanced Skin Cancer
Immunotherapy Trial Yields New Skin Cancer Strategies
Pfizer Combo Halves Death Risk in BRAF V600E Cancer
Triple Therapy Boosts Survival in BRAF V600E Colon Cancer
ASCO: Triple Therapy Boosts Survival in Metastatic Colorectal Cancer
AACR: New Topical Treatment Eases Cancer Therapy Rash
Pfizer Unveils Bold Cancer Care Vision at ASCO 2025
Lancet: Drug Shows No Benefit for Head, Neck Cancer
Pfizer's BRAFTOVI Regimen Boosts Survival in Phase 3 Trial
Dual Therapies Boost Response in BRAF-Mutated Colon Cancer
Dual-Therapy Combo Boosts Response in BRAF-Colorectal Cancer
Radiotherapy Plus Cetuximab Tops Solo in Head, Neck Cancer
Patients Still Top Priority
FDA Greenlights Pfizer Combo for Metastatic Colorectal Cancer
Cetuximab Tops Durvalumab for Head, Neck Cancers
Ferroptosis Key in Digestive Tumor Treatment Tolerance
Medicines Access Expands After Budget Boost
Medicines Access on Rise
Research Reveals How Oral Cancer Evades Immune System
Pfizer's BRAFTOVI + MEKTOVI Shows Long-Term Benefits in NSCLC
Pembrolizumab Boosted by SEphB4-HSA in HPV-Negative HNSCC
New Zealand's Pharmac Receives Boost for Cancer Drugs, Issues Remain
New Radiation Therapy Guidelines for HPV-Linked Head, Neck Cancer
Two-Prong Strategy Enhances Immunotherapy in Studies
King's College Scientists Develop Custom Breast Cancer Drug
Tailored Drug for Aggressive Breast Cancer Developed by Scientists
AACR: Combo Treatment Effective Against Metastatic Colorectal Cancer
Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients
IASLC 2023: NRG Oncology-RTOG 0617 Reveals 5-Year Results for Advanced Lung Cancer
Advanced Lung Cancer Patients Benefit Long-Term from IMRT
Intensity-Modulated Radiation Boosts Long-Term Lung Cancer Survival
Research Could Enhance Therapy for Select Lung Cancer Patients
City of Hope Scientists Develop Universal Solid Tumor Killer
Cetuximab Shows Efficacy and Toxicity in Advanced Cutaneous Squamous Cell Skin Cancer
Head and Neck Cancer Organoids Pave Way for Personalized Treatments
FDA OKs Pfizer's Supplemental New Drug Apps for BRAFTOVI + MEKTOVI
Unusual drug combo shows promise for advanced head, neck cancer without HPV
NRG Oncology trial NRG-HN004 reveals addition of durvalumab to radiation does not improve outcomes over cetuximab for head & neck
MD Anderson and Erasca announce strategic research and development collaboration in RAS/MAPK-driven cancers
How shape-shifting receptor influences cell growth
PBS listing for BRAFTOVI + cetuximab for metastatic bowel cancer patients with BRAFV600 mutation
Improving drug options for colorectal cancer patients
Identifying unique genetic variants to overcome cancer treatment barriers
A novel "biological missile" targeting malignant tumor
Imfinzi combined with novel immunotherapies improved clinical outcomes for patients with unresectable
RAS reversion in colorectal cancer patients treated with bevacizumab